DAX22.462 -1,0%ESt505.331 -0,9%Top 10 Crypto12,01 -0,9%Dow41.584 -1,7%Nas17.323 -2,7%Bitcoin75.429 -0,8%Euro1,0835 +0,1%Öl73,31 -0,1%Gold3.109 +0,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T Rheinmetall 703000 NVIDIA 918422 Novo Nordisk A3EU6F Amazon 906866 RENK RENK73 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 BYD A0M4W9 Allianz 840400 Microsoft 870747 Volkswagen (VW) vz. 766403 Nike 866993
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen mit tiefrotem Wochenausklang -- DAX geht schwächer ins Wochenende -- CureVac mit Erfolg im Patentstreit mit BioNTech -- CoreWeave-IPO, NEL, RENK, Novo Nordisk, Deutsche Bank, IONOS im Fokus
Top News
D-Wave Quantum-Studie: So soll Bitcoin-Mining deutlich effizienter werden D-Wave Quantum-Studie: So soll Bitcoin-Mining deutlich effizienter werden
Diese Aktien empfehlen Experten zu verkaufen Diese Aktien empfehlen Experten zu verkaufen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
+++ Täglich neue Trading-Ideen mit Tradespot by finanzen.net! Jetzt laden! +++

DBV TECHNOLOGIES Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
1,07 EUR +0,33 EUR +44,01 %
STU
1,08 EUR +0,30 EUR +38,28 %
PAR
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.110,75 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JWB7

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINFR0010417345

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDBVTF

DBV TECHNOLOGIES Aktien News

DatumMeistgelesen
GlobeNewswireDBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
GlobeNewswireDBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Rep
GlobeNewswireDBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
Wer­bungDBV TECHNOLOGIES-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswireDBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
GlobeNewswireDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
GlobeNewswireInformation regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
GlobeNewswireDBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswireDBV Technologies Reports Third Quarter 2024 Financial Results
GlobeNewswireDBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
GlobeNewswireDBV Technologies to Participate in Upcoming ACAAI 2024 Congress
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
GlobeNewswireDBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
GlobeNewswireDBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
GlobeNewswireDBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
GlobeNewswireDBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswireDBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
GlobeNewswireDBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswireDBV Technologies to Participate in Upcoming EAACI 2024 Congress
GlobeNewswireDBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswireDBV Technologies Announces Results of its 2024 Combined General Meeting
GlobeNewswireDBV Technologies to Participate in Upcoming Investor Conferences
GlobeNewswireDBV Technologies Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswireCombined General Meeting of May 16, 2024
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
GlobeNewswireDBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
GlobeNewswireDBV Technologies Reports Full Year 2023 Financial Results and Business Update
GlobeNewswireDBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
GlobeNewswireDBV Technologies to Participate in Upcoming AAAAI 2024 Congress
GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  
GlobeNewswireDBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
GlobeNewswireMonthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
GlobeNewswireDBV Technologies to Present New Data at ACAAI 2023
GlobeNewswireDBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
GlobeNewswireDBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
GlobeNewswireDBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
Wer­bung

DBV TECHNOLOGIES News

DBV TECHNOLOGIES News: auf dieser Seite finden Sie alle DBV TECHNOLOGIES News und Nachrichten zur DBV TECHNOLOGIES Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch DBV TECHNOLOGIES News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um DBV TECHNOLOGIES News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.